114 related articles for article (PubMed ID: 5314713)
21. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
Hunyi L
Ther Hung; 1978; 26(2):77-80. PubMed ID: 684660
[No Abstract] [Full Text] [Related]
22. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
Fisanovich TI; Tolstova LG
Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
[No Abstract] [Full Text] [Related]
23. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
Bagliani A; Borri P; Parravicini R
Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
[No Abstract] [Full Text] [Related]
24. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
Valiensi M; Riboli E; Lombardi M
Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
[No Abstract] [Full Text] [Related]
25. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
Majkowski J; Lysakowska-Sernicka K; Gajewska A; Bilińska-Nigot B; Ostrowski K; Semenicki K
Neurol Neurochir Pol; 1978; 12(4):387-96. PubMed ID: 714218
[TBL] [Abstract][Full Text] [Related]
26. Treatment of occlusive diseases of the arteries in the limbs with pyridinol-carbamate.
Matsumoto K; Sato K; Tanaka S
Jpn Heart J; 1966 Jan; 7(1):87-93. PubMed ID: 5295647
[No Abstract] [Full Text] [Related]
27. CLINICAL AND PLETHYSMOGRAPHIC OBSERVATIONS ON THE USE OF CYCLANDELATE IN ARTERIOSCLEROSIS OBLITERANS.
FREMONT RE
Am J Med Sci; 1964 Feb; 247():182-95. PubMed ID: 14124708
[No Abstract] [Full Text] [Related]
28. [Pyridinolcarbamate in the treatment of peripheral vascular diseases in diabetics. Observations after 3 years of clinical use].
Parodi FA
Minerva Med; 1974 May; 65(40):2316-20. PubMed ID: 4421119
[No Abstract] [Full Text] [Related]
29. [Treatment of arteriosclerosis obliterans with pyridinolcarbamate].
Atsumi T; Isokane N; Yamashita S; Sano T; Odakura T; Kurai A
Nihon Naika Gakkai Zasshi; 1967 Sep; 56(9):983-92. PubMed ID: 5627161
[No Abstract] [Full Text] [Related]
30. Pulse morphological plethysmography of the forefoot in arteriosclerosis obliterans.
Mune O
Scand J Clin Lab Invest Suppl; 1967; 99():142-6. PubMed ID: 6056910
[No Abstract] [Full Text] [Related]
31. The natural course of peripheral arteriosclerosis obliterans evaluated by flow measurements.
Bollinger A; Simon HJ; Mahlrer F
Angiology; 1969 Jul; 20(7):414-21. PubMed ID: 5802451
[No Abstract] [Full Text] [Related]
32. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
Vaccaro E; Solitro A; Barba C
Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
[No Abstract] [Full Text] [Related]
33. [On the therapy of peripheral organo-angiopathies using Progresin].
Horn HJ
Med Klin; 1968 Aug; 63(35):1377-8 passim. PubMed ID: 5682033
[No Abstract] [Full Text] [Related]
34. Failure of vasodilator drugs in arteriosclerosis obliterans.
Coffman JD; Mannick JA
Ann Intern Med; 1972 Jan; 76(1):35-9. PubMed ID: 4553743
[No Abstract] [Full Text] [Related]
35. [ON THE CHANGES IN PERIPHERAL ARTERIAL STETHO-ACOUSTIC FINDINGS AFTER THE EXERCISE TEST].
PENNETTI V; DIRENZI L; MELARAGNO E; GUERRIZIO L
Boll Soc Ital Cardiol; 1964; 9():1-5. PubMed ID: 14134479
[No Abstract] [Full Text] [Related]
36. [Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].
Pola P; Savi L; Dal Lago A; Zucchiatti V
Clin Ter; 1977 Jun; 81(5):417-31. PubMed ID: 884936
[No Abstract] [Full Text] [Related]
37. The effect of vasodilating drugs in peripheral vascular disease.
Karpman HL; Okun R
Geriatrics; 1972 Nov; 27(11):101-7. PubMed ID: 4562846
[No Abstract] [Full Text] [Related]
38. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
Seghezzi R; Pedroni G; Borri P
Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
[No Abstract] [Full Text] [Related]
39. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
[TBL] [Abstract][Full Text] [Related]
40. Arteriosclerosis obliterans: clinical diagnosis and treatment.
DeWolfe VG
Geriatrics; 1973 Sep; 28(9):93-101. PubMed ID: 4725693
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
